Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;11(1):205-213.
doi: 10.1007/s11682-016-9523-8.

Sex differences in the association between AD biomarkers and cognitive decline

Affiliations

Sex differences in the association between AD biomarkers and cognitive decline

Mary Ellen I Koran et al. Brain Imaging Behav. 2017 Feb.

Abstract

Women are disproportionately affected by Alzheimer's disease (AD) in terms of both disease prevalence and severity. Previous autopsy work has suggested that, in the presence of AD neuropathology, females are more susceptible to the clinical manifestation of AD. This manuscript extends that work by evaluating whether sex alters the established associations between cerebrospinal fluid (CSF) biomarker levels and brain aging outcomes (hippocampal volume, cognition). Participants were drawn from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and included individuals with normal cognition (n = 348), mild cognitive impairment (n = 565), and AD (n = 185). We leveraged mixed effects regression models to assess the interaction between sex and baseline cerebrospinal fluid biomarker levels of amyloid-β42 (Aβ-42) and total tau on cross-sectional and longitudinal brain aging outcomes. We found a significant interaction between sex and Aβ-42 on longitudinal hippocampal atrophy (p = 0.002), and longitudinal decline in memory (p = 0.017) and executive function (p = 0.025). Similarly, we observed an interaction between sex and total tau level on longitudinal hippocampal atrophy (p = 0.008), and longitudinal decline in executive function (p = 0.034). Women with Aβ-42 and total tau levels indicative of worse pathological changes showed more rapid hippocampal atrophy and cognitive decline. The sex difference was particularly pronounced among individuals with MCI, with lower education, and varied by APOE ε4 allele. These results suggest females may be more susceptible to the clinical manifestation of AD.

Keywords: Alzheimer’s disease; Biomarkers; Cognition; Hippocampus; Sex differences.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1. Females show a faster rate of hippocampal atrophy in the presence of enhanced (low levels) of CSF Aβ-42. (IMAGE FOR REVIEW PURPOSES ONLY)
CSF Aβ-42 levels are along the x-axis. Annual change in left hippocampal volume is along the y axis. Sex is differentiated by color with males in red and females in blue. The gray shading around the regression line represents the standard error.
Figure 2
Figure 2. Females show a faster rate of hippocampal atrophy in the presence of enhanced CSF tau levels
CSF Aβ-42 levels are along the x-axis. Annual change in right hippocampal volume is along the y axis. Sex is differentiated by color with males in red and females in blue. The gray shading around the regression line represents the standard error.

References

    1. Alvarez-de-la-Roza M, Silva I, Nilsen J, Perez M, Garcia-Segura LM, Ávila J, Naftolin F. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Annals of the New York Academy of Sciences. 2005;1052(1):210–224. - PubMed
    1. Anastasio TJ. Exploring the contribution of estrogen to amyloid-beta regulation: a novel multifactorial computational modeling approach. Frontiers in Pharmacology. 2013;4 doi: 10.3389/fphar.2013.00016. - DOI - PMC - PubMed
    1. Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain. 2006;129(11):2867–2873. - PubMed
    1. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Archives of General Psychiatry. 2005;62(6):685–691. - PubMed
    1. Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, … Harvey D. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Brain Imaging and Behavior. 2012;6(4):502–516. - PMC - PubMed

Publication types

MeSH terms